Beijing Tiantan Biological Products Co., Ltd.
600161
Classifica tra le azioni
#4320
Beijing Tiantan Biological Products Co., Ltd., established in 1998 and... Beijing Tiantan Biological Products Co., Ltd., established in 1998 and headquartered in Beijing, China, is actively involved in the full spectrum of blood product operations within China. This includes pioneering research and development, manufacturing, sales, and providing consultancy services. Its comprehensive product line features critical blood-derived medicines such as intravenous immunoglobulin, human albumin, and various specialized human immunoglobulins for conditions like hepatitis B (both standard and freeze-dried formulations) and tetanus, alongside other general human immunoglobulin preparations and intravenous blood system solutions. The company operates as a subsidiary of China National Biotec Group Company Limited.
Prezzo delle azioni
$1.81
Capitalizzazione di mercato
$3.59B
Variazione (1 giorno)
-0.90%
Variazione (1 anno)
-32.39%
Paese
CN
Scambia Beijing Tiantan Biological Products Co., Ltd. (600161)
Categoria
Healthcare
Rapporto P/S per Beijing Tiantan Biological Products Co., Ltd. (600161)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Beijing Tiantan Biological Products Co., Ltd., il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per Beijing Tiantan Biological Products Co., Ltd. da 2001 a 2026
Rapporto P/S alla fine di ogni anno
| Anno | Rapporto P/S | Cambia |
|---|---|---|
| 2025 | 5.26 | -22.02% |
| 2024 | 6.75 | -31.59% |
| 2023 | 9.87 | 29.06% |
| 2022 | 7.64 | -2.32% |
| 2021 | 7.83 | -38.14% |
| 2020 | 12.65 | 70.59% |
| 2019 | 7.42 | 52.05% |
| 2018 | 4.88 | -27.59% |
| 2017 | 6.74 | -14.86% |
| 2016 | 7.91 | -11.86% |
| 2015 | 8.98 | 47.94% |
| 2014 | 6.07 | 21.46% |
| 2013 | 5.00 | 40.08% |
| 2012 | 3.57 | -28.46% |
| 2011 | 4.98 | -38.91% |
| 2010 | 8.16 | -21.53% |
| 2009 | 10.40 | 15.36% |
| 2008 | 9.02 | -64.41% |
| 2007 | 25.33 | 92.70% |
| 2006 | 13.15 | 352.30% |
| 2005 | 2.91 | 11.39% |
| 2004 | 2.61 | -15.56% |
| 2003 | 3.09 | -18.48% |
| 2002 | 3.79 | -22.37% |
| 2001 | 4.88 | 0.00% |
Rapporto P/S per aziende simili o concorrenti
| Azienda | Rapporto P/S | Differenza del rapporto P/S | Il paese |
|---|---|---|---|
| 10.02 | - |
US
|
|
| 40.55 | - |
US
|
|
| 3.96 | - |
AU
|
|
| 10.15 | - |
NL
|
|
| - | - |
CH
|
